It is projected that the airway management devices market share will be valued US$ 1.6 billion in 2023 and increase at a compound annual growth rate (CAGR) of 3.6% to reach US$ 2.2 billion by 2033.
One of the main factors propelling the market is anticipated to be the increasing prevalence of respiratory illnesses. 65 million persons worldwide are estimated by the WHO to have moderate-to-severe COPD. Moreover, COPD is predicted to rank as the third leading cause of death worldwide.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7775
This high incidence, combined with an increase in anaesthetic consumption as a result of many surgeries, is likely to drive demand for advanced equipment, positively impacting the overall market growth. The growing demand for emergency treatment for long-term illnesses, as well as long-term therapy for lung disorders in children and adults, is also anticipated to fuel market expansion.
In the current scenario, growing awareness of inadequate ventilation and the introduction of relatively advanced procedures for preoperative airway examination are projected to broaden the possibility for product penetration in the future years. Preoperative Endoscopic Airway Evaluation (PEAE), for example, aids in the identification and prediction of blocked ventilation, as well as the design of an effective management strategy that focuses on the use of advanced equipment like supraglottic airway.
Key Takeaways :
- The market is estimated to drive due to increased demand for emergency and intensive care.
- The rise in the prevalence of respiratory diseases is likely to drive the growth of the market for airway management devices.
- The airway management devices market is expected to be worth US$ 1.6 billion in 2023.
- Airway management devices market is forecasted to register a 3.6% CAGR from 2023 to 2033.
- North America is likely to dominate the market for airway management devices market.
Recent Developments:
- Verathon Inc. introduced the GlideScope Core 15 airway visualisation system in January 2020, which employs a 15-inch high-definition touchscreen monitor to provide improved visibility.
- In January 2020, Smiths Medical, Inc. announced the expansion of its Portex Tracheostomy Tubes and Kits line by releasing a PVC-based tracheostomy tube range. The portfolio includes BLUperc, BLUselect tracheostomy tubes, and BLUgriggs percutaneous tracheostomy kits and trays.
- Olympus Corporation, a global technology leader in inventing and delivering new solutions for surgical and medical procedures, among other core activities, announced the release of two video rhino-laryngoscopes in September 2019. It is proposed that the ENF-VH2/V4 be specially constructed for laryngological tests.
- In September 2018, Royal Philips announced the development of a resuscitation device in conjunction with the Consortium for Affordable Medical Technologies (CAMTech) to aid in the reduction of infant mortality.
- In January 2019, Oventus Medical, a medical device business, unveiled O2 Vent Optima, a new product. It is used to treat obstructive sleep apnea. It is based on the airway technology developed by Oventus Medical. It keeps the airway from contracting and allows for unrestricted airflow from the tongue, soft palate, and nose. It is suitable for usage with or without continuous positive airway pressure.
Key Companies:
- Medtronic Plc
- Teleflex Incorporated
- Ambu A/S
- Smith’s Group plc.
- Intersurgical Ltd.
- Cook Medical Inc.
- SunMed
- Vyaire Medical Inc
- VBM Medizintechnik GmbH
- Karl Storz SE & Co. KG
- Cook Gas LLC
- Flexicare (Group) Limited
- BVLM Pty Ltd
- Boston Medical Products Inc. (BESS GROUP)
- Salter Labs
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7775
Key Segments :
By Product Type:
- Laryngeal Masks
- Tracheostomy Tubes
- Endotravheal Tubes
- EndoBronhial Tubes
- Nasal Airway Tubes
- Oral Airway Tubes.
By Usage Type:
- Single Use/ Disposable
- Reusable
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
